Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.

AIMS Biophysics, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing the fields of biophysics, biochemistry, molecular biology, and structural biology. Launched in 2014, this journal provides a platform for researchers and professionals to disseminate high-quality research findings that contribute to the understanding of complex biological systems at the molecular level. With an ISSN of 2377-9098, AIMS Biophysics is indexed in Scopus, where it ranks in the fourth quartile across several categories, reflecting its commitment to addressing important issues within the scientific community. The journal aims to foster interdisciplinary collaboration and innovation through the publication of original research, reviews, and methodologies that advance the field. The open-access model ensures that cutting-edge research is freely available, promoting global access to scientific knowledge and enhancing visibility for authors. Nestled in the vibrant scientific landscape of the United States, AIMS Biophysics is poised to impact the evolving discourse in biophysics and related areas as it continues through its convergence period from 2014 to 2024.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

The Journal of Molecular Biology (ISSN: 0022-2836, E-ISSN: 1089-8638), published by Academic Press Ltd - Elsevier Science Ltd, stands as a premier platform for disseminating significant advancements in the field of molecular biology. With a distinguished history of publication spanning from 1959 to 2024, this journal is recognized for its high-quality, peer-reviewed articles that engage with transformative research in biophysics, structural biology, and molecular biology. The journal holds an impressive Q1 category ranking across these disciplines in 2023, affirming its impact and relevance within the scientific community. Notably, it ranks #11 in biophysics and #5 in structural biology based on Scopus metrics, placing it in the 93rd and 90th percentiles, respectively. As an essential resource for researchers, professionals, and students alike, the Journal of Molecular Biology serves as a vital conduit for the exchange of innovative ideas and discoveries, fostering a deeper understanding of life's molecular underpinnings.

Biophysics Reviews, published by AIP Publishing, is an emerging journal in the field of biophysics, aiming to bridge the gap between fundamental biophysical research and applied sciences. With an ISSN of 2688-4089, this journal provides a critical platform for the dissemination of high-quality reviews covering the interplay between biochemistry, molecular biology, biotechnology, and materials science. As of 2023, it provides essential insights for researchers and professionals interested in understanding biomolecular processes at a physical level. Although the journal is not currently open access, it is making strides in establishing its impact in the competitive landscape, as indicated by its Scopus rankings in various related fields, including biochemistry and bioengineering. With a focus on enhancing collaborations among scientists and practitioners, Biophysics Reviews is poised to become a vital resource for anyone looking to deepen their understanding of how biophysical principles can be applied to solve complex biological challenges.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, published by Elsevier, is a prestigious academic journal that serves as a vital resource for researchers, professionals, and students in the fields of biochemistry, biophysics, and proteomics. With an ISSN of 1570-9639 and an E-ISSN of 1878-1454, this journal features high-impact research articles aimed at advancing our understanding of protein structure, function, and interactions, contributing significantly to both theoretical and applied sciences. Recognized for its quality, it proudly holds a Q1 ranking in Analytical Chemistry and Biophysics, and Q2 in Biochemistry for 2023, alongside notable Scopus rankings that reflect its influence in the realm of molecular biology. The journal's commitment to disseminating essential findings supports the ongoing evolution of proteomic sciences and encourages collaborative discourse among the global scientific community. For aspiring authors, the journal offers open access options, enabling broad visibility of their work. Join the conversation in this dynamic field and contribute to shaping the future of protein research!

NATURE REVIEWS MOLECULAR CELL BIOLOGY, published by NATURE PORTFOLIO, stands as a seminal journal in the fields of cell and molecular biology, with a significant impact factor that underscores its influence and reputation within the scientific community. Established in 2000 and continuing its legacy into 2024, this journal delivers comprehensive reviews that synthesize current knowledge and advancements in molecular and cellular processes. Respected for its high-quality articles, it has maintained a prestigious Q1 ranking in both Cell Biology and Molecular Biology categories as of 2023. With an exceptional Scopus ranking, taking the top position in its category, it attracts a readership of prominent researchers, professionals, and students eager to stay abreast of groundbreaking discoveries and methodologies. Although it does not offer Open Access, subscribers benefit from exclusive access to vital insights that foster innovative research approaches and advancements in the life sciences. The journal’s objective is to bridge the gap between research and application, providing indispensable resources to its audience while contributing to the global conversation on molecular and cellular biology.

GENERAL PHYSIOLOGY AND BIOPHYSICS, published by AEPRESS SRO, is a pivotal journal in the fields of biophysics and physiology, dedicated to advancing knowledge and fostering research in these increasingly vital disciplines. Established in 1983 and set to converge in 2024, the journal provides a platform for scholarly articles that explore the intricate relationships between biological systems and physical principles. Its current category quartiles include Q3 in Biophysics and Q4 in Physiology, demonstrating a growing influence among researchers, with current Scopus ranks reflecting its commitment to quality and relevance. Despite not being an open-access publication, the journal remains a valuable resource for professionals and students aiming to stay informed on the latest discoveries and methodologies. By supporting interdisciplinary research and innovation, GENERAL PHYSIOLOGY AND BIOPHYSICS plays a crucial role in shaping the understanding of complex biological interactions and applications in medicine.

Integrative Biology, published by Oxford University Press, is a dynamic journal at the intersection of biochemistry, biophysics, and broad spectrum medicine. Since its inaugural issue in 2009, the journal has established itself as a significant platform for disseminating transformative research that explores the integration of biological disciplines. With a commendable Q2 ranking in Biophysics and a Q3 ranking in Biochemistry for 2023, it attracts high-quality submissions and maintains rigorous peer-review standards. The journal serves as an essential resource for researchers, professionals, and students seeking to advance their understanding of complex biological systems through innovative and interdisciplinary approaches. While currently not an open access publication, it offers various access options to cater to its diverse readership. With an ongoing commitment to fostering collaboration and knowledge exchange within the scientific community, Integrative Biology continues to play a pivotal role in shaping contemporary biological research.